Close

Form 3 ChromaDex Corp. For: Aug 11 Filed by: Gerber Brianna

August 12, 2022 9:05 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Gerber Brianna

(Last) (First) (Middle)
10900 WILSHIRE BLVD. SUITE 600

(Street)
LOS ANGELES CA 90024

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/11/2022
3. Issuer Name and Ticker or Trading Symbol
ChromaDex Corp. [ CDXC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP Finance / Interim CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,238
I
See footnote (1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (right to buy) 09/17/2017 (2) 11/30/2028 Common Stock 11,140 3.55 D  
Employee Stock Options (right to buy) 02/21/2020 (3) 02/21/2029 Common Stock 22,266 3.84 D  
Employee Stock Options (right to buy) 02/25/2021 (4) 02/25/2030 Common Stock 60,000 3.27 D  
Employee Stock Options (right to buy) 08/06/2021 (5) 08/05/2030 Common Stock 10,000 4.92 D  
Employee Stock Options (right to buy) 03/15/2022 (6) 03/14/2031 Common Stock 32,000 11.83 D  
Employee Stock Options (right to buy) 02/17/2023 (7) 02/16/2032 Common Stock 56,576 2.67 D  
Explanation of Responses:
1. 1,238 shares held by Jacob Gerber who is a spouse of Brianna Gerber.
2. One-third of the shares subject to the option vested on September 17, 2017 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of August 11, 2022.
3. One-third of the shares subject to the option vested on February 21, 2020 and the remaining shares subject to the option have vested in a series of 24 equal monthly installments thereafter. The stock options are fully vested as of August 11, 2022.
4. One-third of the shares subject to the option vested on February 25, 2021 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.
5. One-third of the shares subject to the option vested on August 6, 2021 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.
6. One-third of the shares subject to the option vested on March 15, 2022 and the remaining shares subject to the option are vesting in a series of 24 equal monthly installments thereafter.
7. One-third of the shares subject to the option shall vest on February 17, 2023 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter.
Remarks:
Exhibit List - 24.1 Power of Attorney
/s/ Jeong James Lee, Attorney-in-Fact 08/12/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
      Know all by these presents, that the undersigned hereby constitutes and appoints each of Jeong James Lee, Nino Tavitian, Mercy Lopez or their designees of ChromaDex Corporation (the "Company"), signing individually, the undersigned's true and lawful attorney-in-fact and agent to: 
      (1) execute for and on behalf of the undersigned, an officer, director or holder of 10% of more of a registered class of securities of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder; 
      (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
      (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
      The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.
      This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact shall no longer be employed by the Company.
      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 11th day of August, 2022.

/s/ Brianna Gerber    
BRIANNA GERBER


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings